FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

Diabetes Device Feasibility Studies Guidance

Federal Register notice: FDA makes available a final guidance entitled Feasibility and Early Feasibility Clinical Studies for Certain Medical Devices ...

Medical Devices

Increase FDA Oversight of Lab-developed Tests: Pew

A new Pew Charitable Trusts survey on lab-developed tests finds that most participants would favor increased FDA oversight in this space.

Human Drugs

Califf Returned to FDA for Unfinished Business

FDA commissioner Robert Califf admits that his return to the FDA top post gives him an opportunity to address unfinished business from the first time ...

Medical Devices

Lasik Injury Advocate Steps Up Pressure on Illegal Ads

Lasik injury advocate and Vision Advocacy president Paula Cofer steps up pressure to get FDA commissioner Robert Califfs attention to address illegal ...

Human Drugs

CDER Study Verifies Continuous Manufacturing Benefits

Eleven CDER staffers say a Center self-audit of continuous manufacturing regulatory submissions verifies the benefits the agency has seen in such tech...

Human Drugs

FDA Approves Enhertu for Some Additional Breast Cancers

FDA approves a new indication for Daiichi Sankyos Enhertu for some breast cancer patients.

Human Drugs

Switching Generic Levothyroxine Maintains Thyroid Function: Study

FDA-sponsored research demonstrates that patients who switch between generic levothyroxine products maintain the same level of thyroid function as pat...

Human Drugs

15 Observations in Qualgen FDA-483

FDA releases the FDA-483 with 15 observations issued following an inspection at the Edmond, OK-based Qualgen outsourcing facility.

Human Drugs

FDA Orders Partial Clinical Hold on BioCryst Therapy

FDA issues a partial clinical hold on BioCryst clinical trial of its oral Factor D inhibitor, BCX9930 due to observed elevations in serum creatinine s...

Federal Register

Info Collection on Antimicrobial Animal Drug Reporting

Federal Register notice: FDA sends to OMB an information collection extension entitled Antimicrobial Animal Drug Distribution Reports and Recordkeepin...